BackEnanta Pharmaceuticals Overview

Enanta Pharmaceuticals Operating Income

Operating Income for ENTA.

Quarterly Operating Income

$-11852000.00
51.68% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-60384000.00
40.86% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)